Search filters

List of works by Monique C Minnema

A Human Hematopoietic Niche Model Supporting Hematopoietic Stem and Progenitor Cells In Vitro

scientific article published on 03 April 2019

A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

scientific article published on 13 May 2020

A RANDOMIZED PHASE 3 TRIAL OF ZANUBRUTINIB VERSUS IBRUTINIB IN SYMPTOMATIC WALDENSTRÖM MACROGLOBULINEMIA:THE ASPEN STUDY

scientific article published on 30 July 2020

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

scientific article published on 30 October 2009

A survey on diagnostic methods and treatment strategies used in patients with Waldenström's macroglobulinaemia in The Netherlands

scientific article published on March 1, 2013

Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

scientific article published on 19 December 2019

Accessory cells of the microenvironment protect multiple myeloma from T-cell cytotoxicity through cell adhesion-mediated immune resistance.

scientific article published on 4 September 2013

Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program

scientific article published in April 2010

Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants

scientific article published on 17 July 2019

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis

scientific article

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95):

scientific article published on 30 April 2020

Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions

scientific article published on 22 March 2010

Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial

scientific article published on 09 March 2020

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial

scientific article published on 28 March 2019

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

scientific article published on 15 June 2016

CXCR4 mutations in lymphoplasmacytic lymphoma lead to altered CXCR4 expression

scientific article published on 08 November 2018

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial

scientific article published on 12 August 2020

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model.

scientific article published on 22 February 2018

Central Nervous System Progression in Primary Vitreoretinal Lymphoma with Bilateral and Unilateral Involvement: A Systematic Review and Meta-Analysis

scientific article published in 2022

Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

scientific article

Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic

scientific article published on 01 June 2020

Clinical management of spinal metastases-The Dutch national guideline

scientific article published on 15 October 2018

Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature review

scientific article published on 27 March 2020

Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses

scientific article published on 20 May 2016

Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review

scientific article published on 25 April 2013

Comparison of the occurrence of mold infection among patients receiving chemotherapy for acute leukemia versus patients undergoing stem cell transplantation ⬇️

scientific article published on July 26, 2011

Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP

scientific article published on 25 December 2019

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

scientific article published on 30 July 2020

Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia

scientific article published on 01 November 2020

Cytomegalovirus Status and the Outcome of T Cell-Replete Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 25 July 2016

Daratumumab Plus CyBorD for Patients With Newly Diagnosed AL Amyloidosis: Safety Run-in Results of ANDROMEDA

scientific article published on 03 April 2020

Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review

scientific article published on 29 May 2018

Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study

scientific article published on 22 March 2012

EBV-related lymphoma after long-term daratumumab treatment: a case report

scientific article published on 04 November 2020

Effective treatment of Bing-Neel Syndrome with oral fludarabine: a case series of four consecutive patients

scientific article

Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients

scientific article published on 14 November 2016

Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement

scientific article published on 29 August 2017

Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients.

scientific article published on 6 August 2018

Endosteal and Perivascular Subniches in a 3D Bone Marrow Model for Multiple Myeloma

scientific article published on 18 April 2018

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study

scientific article published on 31 March 2019

Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome.

scientific article published on 14 January 2008

Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment

scientific article published in March 2003

False-positive PET scan after bone marrow biopsy

scientific article published on 7 May 2013

Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia

scientific article published on March 1, 2013

Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome

scientific article

Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016

scientific article published on 04 December 2018

High level of perforin expression in T cells: An early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults

scientific article published in March 2010

High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy.

scientific article published on 10 October 2017

Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT ⬇️

scientific article published on June 17, 2013

Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis

scientific article published on 01 December 2005

Identification of minor histocompatibility antigens based on the 1000 Genomes Project

scientific article

Implantable defibrillators in cardiac amyloidosis

scientific article published on 16 September 2012

In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review

scientific article

Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients ⬇️

scientific article published on April 1, 2011

Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma

scientific article published in January 2010

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.

scientific article

Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

scientific article published on 20 June 2011

Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma

scientific article published on 29 November 2018

MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma

scientific article published on 08 November 2018

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

scientific article

Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities

scientific article published on 17 May 2018

Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options

scientific article published on 01 September 2019

Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting

scientific article published on 01 December 2019

New developments in the treatment of patients with multiple myeloma

scientific article published on January 2010

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

scientific article published on 08 January 2019

Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.

scientific article

Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma

scientific article published on 02 January 2019

Phase 2 study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma, the carthadex trial

scientific article published on 04 April 2019

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate n

scientific article published on October 8, 2011

Possibilities and limitations of an in vitro three-dimensional bone marrow model for the prediction of clinical responses in patients with relapsed multiple myeloma

scientific article published on 19 April 2019

Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy

scientific article published in December 2004

Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience

scientific article published on 19 April 2010

Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study

scientific article

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

scientific article published on 05 July 2016

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

scientific article published on 4 September 2015

Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes

scientific article published on 29 July 2016

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

scientific article published on 07 January 2019

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.

scientific article published on 5 May 2016

Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions induced

scientific article published on 01 May 2007

Sporadic late-onset nemaline myopathy effectively treated by melphalan and stem cell transplant

scientific article published on 18 June 2008

Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT.

scientific article published on 5 November 2014

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

scientific article

Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial

scientific article published on 01 October 2018

The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective

scientific article published on 26 February 2016

The Dutch national guideline on metastases and hematological malignancies localized within the spine; a multidisciplinary collaboration towards timely and proactive management

scientific article published on 29 May 2018

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study

scientific article

The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry

scientific article published on 23 January 2017

The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid

scientific article published on 6 December 2017

Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis

scientific article published on 10 November 2008

Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.

scientific article published on October 2012

Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review

scientific article published on 01 July 2018

Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir.

scientific article published on 9 August 2015

Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

scientific article published on 18 July 2016

Unexpected symptoms of monoclonal gammopathy

scientific article published in January 2017

[Spinal metastases: early recognition and a multidisciplinary approach]

scientific article published on 12 July 2019

Paulina is supported by:

About Paulina

Help